✦ LIBER ✦

Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer

✍ Scribed by E. G. E. de Vries; S. Rodenhuis; H. C. Schouten; P. S. G. J. Hupperets; W. V. Dolsma; J. V. Lebesque; G. H. Blijham; M. Bontenbal; N. H. Mulder

Publisher: Springer US
Year: 1996
Tongue: English
Weight: 569 KB
Volume: 39
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01806158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monitoring of disseminated tumor cells i

Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy

✍ Vilde Drageset; Jahn M. Nesland; Bjorn Erikstein; Eva Skovlund; Hilde Sommer; Gu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 1 views

## Abstract The present study aimed to investigate the clinical relevance of disseminated tumor cells (DTC) in breast cancer patients before and after high‐dose adjuvant chemotherapy with or without progenitor stem‐cell support. One hundred and eighteen high‐risk stage II breast cancer patients ent

Autologous and allogeneic bone marrow tr

Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: an update of the Genoa experience with 159 patients

✍ A. M. Carella; F. Frassoni; M. T. van Lint; F. Gualandi; D. Occhini; P. Carlier; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 318 KB

Phase-I–II study of high-dose melphalan

Phase-I–II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas

✍ B. Mascret; D. Maraninchi; J. A. Gastaut; D. Baume; G. Sebahoun; C. Lejeune; G. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 587 KB

Intensive chemotherapy with high doses o

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

✍ M. H. Gaspard; D. Maraninchi; A. M. Stoppa; J. A. Gastaut; G. Michel; N. Tubiana 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 688 KB

Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, thre

The feasibility of neoadjuvant high-dose

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma : Results of a phase II study

✍ Fikret Arpaci; Selmin Ataergin; Ahmet Ozet; Kaan Erler; Mustafa Basbozkurt; Ayha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract ## BACKGROUND The primary and secondary objectives of the current study were to improve the ≥ 90% tumor necrosis rate and assess the toxicity profile of the neoadjuvant high‐dose chemotherapy (HDC) regimen, respectively. ## METHODS Twenty‐two patients with AJCC Stage IIB high‐grade o